In conclusion, we described a paradigm in which through CD44, the signaling network consisting of AKT, ERK and Hippo-YAP pathways controls the expression of downstream genes that mediate contact inhibition, proliferation, cell cycle progression and maintenance of tumor initiating cells. The gene discussed is CD44; the disease is neoplasm.